Tsumura & Co. (4540.T)

JPY 4301.0

(-0.53%)

Net Debt Summary of Tsumura & Co.

  • Tsumura & Co.'s latest annual net debt in 2023 was 1.61 Billion JPY , up 110.72% from previous year.
  • Tsumura & Co.'s latest quarterly net debt in 2024 Q1 was 7.16 Billion JPY , up 343.34% from previous quarter.
  • Tsumura & Co. reported annual net debt of -15.06 Billion JPY in 2022, up 15.68% from previous year.
  • Tsumura & Co. reported annual net debt of -17.86 Billion JPY in 2021, down -111.18% from previous year.
  • Tsumura & Co. reported quarterly net debt of 1.61 Billion JPY for 2023 Q4, up 289.78% from previous quarter.
  • Tsumura & Co. reported quarterly net debt of 1.61 Billion JPY for 2023 FY, up 110.72% from previous quarter.

Annual Net Debt Chart of Tsumura & Co. (2023 - 2004)

Historical Annual Net Debt of Tsumura & Co. (2023 - 2004)

Year Net Debt Net Debt Growth
2023 1.61 Billion JPY 110.72%
2022 -15.06 Billion JPY 15.68%
2021 -17.86 Billion JPY -111.18%
2020 -8.45 Billion JPY -355.45%
2019 3.31 Billion JPY 114.68%
2018 -22.55 Billion JPY -19.76%
2017 -18.83 Billion JPY -368.0%
2016 7.02 Billion JPY -40.49%
2015 11.8 Billion JPY -32.83%
2014 17.57 Billion JPY 134.0%
2013 7.51 Billion JPY -7.99%
2012 8.16 Billion JPY 1.82%
2011 8.01 Billion JPY 39.74%
2010 5.73 Billion JPY -25.63%
2009 7.71 Billion JPY -28.11%
2008 10.73 Billion JPY -31.82%
2007 15.73 Billion JPY 0.52%
2006 15.65 Billion JPY -58.87%
2005 38.07 Billion JPY -22.23%
2004 48.95 Billion JPY 0.0%

Peer Net Debt Comparison of Tsumura & Co.

Name Net Debt Net Debt Difference
Pharma Foods International Co., Ltd. 1.22 Billion JPY -31.837%
Takeda Pharmaceutical Company Limited 4385.95 Billion JPY 99.963%
Sumitomo Pharma Co., Ltd. 389.83 Billion JPY 99.586%
Shionogi & Co., Ltd. -346.47 Billion JPY 100.466%
Wakamoto Pharmaceutical Co.,Ltd. -3.56 Billion JPY 145.313%
Nippon Shinyaku Co., Ltd. -42.15 Billion JPY 103.831%
Kaken Pharmaceutical Co., Ltd. -61.47 Billion JPY 102.627%
Eisai Co., Ltd. -97.93 Billion JPY 101.649%
Morishita Jintan Co., Ltd. -667 Million JPY 342.129%
Hisamitsu Pharmaceutical Co., Inc. -51.82 Billion JPY 103.116%
Mochida Pharmaceutical Co., Ltd. -32.92 Billion JPY 104.906%
Fuso Pharmaceutical Industries,Ltd. 7.6 Billion JPY 78.756%
Nippon Chemiphar Co., Ltd. 7.78 Billion JPY 79.244%
Kissei Pharmaceutical Co., Ltd. -44.16 Billion JPY 103.657%
Torii Pharmaceutical Co., Ltd. -34.43 Billion JPY 104.69%
Towa Pharmaceutical Co., Ltd. 172.7 Billion JPY 99.065%
Fuji Pharma Co., Ltd. 26.62 Billion JPY 93.934%
Zeria Pharmaceutical Co., Ltd. 28.98 Billion JPY 94.428%
KYORIN Holdings, Inc. 7.06 Billion JPY 77.125%
Taiko Pharmaceutical Co.,Ltd. 704 Million JPY -129.403%
Daito Pharmaceutical Co.,Ltd. 5.99 Billion JPY 73.047%
SymBio Pharmaceuticals Limited -6.51 Billion JPY 124.781%
MedRx Co., Ltd -1.72 Billion JPY 193.895%
Mizuho Medy Co.,Ltd. -8.71 Billion JPY 118.528%
Solasia Pharma K.K. -668 Million JPY 341.766%
Modalis Therapeutics Corporation -1.47 Billion JPY 209.794%
ASKA Pharmaceutical Holdings Co.,Ltd. -7.25 Billion JPY 122.267%
Sawai Group Holdings Co., Ltd. 56.52 Billion JPY 97.143%
Cyfuse Biomedical K.K. -2.96 Billion JPY 154.547%
Toho Holdings Co., Ltd. -98.42 Billion JPY 101.641%
Koa Shoji Holdings Co.,Ltd. -11.12 Billion JPY 114.511%